You're reading the free version. Trader adds the live tape and alerts.
Start tracking
TELO Award Disclosure
Whalen Matthew Pratt · SEC Form 4 · Filed Jul 27, 2026
Award
Calculated transaction value
$0
Whalen Matthew Pratt Director
TELO
Transaction date
Apr 16, 2026
Public filing date
Jul 27, 2026
Filing lag
Filed 102 days later
TELO daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Non-Qualified Stock Options (right to buy) on Common Stock
- Quantity / price
- 50,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001493152-26-034813
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. TELO Current | Award | Apr 16, 2026 | $0 |